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ABSTRACT
O b je c tiv e : The aim of this study was to optimize the 
diagnosis of the fragile X syndrome in six large families 
with fragile X syndrome in Turkey.
M e th o d s : Southern blot analysis was performed to 
identify the mutations of the FMR 1 gene localized on 
FRAXA locus using StB12.3 probe among 36 
members (19 males, 17 females) of fragile X families 
and controls (8  males, 8 females) following cytogenetic 
analysis by fragile X induction methods.
R e s u lts :  Eleven males and 9 females had full 
mutations, while 7 males and 3 females had normal 
range of CGG repeats. One female who was found 
positive by cytogenetic analysis had mosaic mutation 
(Y2[ll-3] with 6.0, 5.2, 2.8 kb fragment sizes). Five 
females had premutations and 1 male had atypical 
fragment pattern.
C o n c lu s io n : We suggest that, diagnosis of fragile X 
syndrome is not possible only by cytogenetic analysis. 
For appropriate counseling it is recommended that all 
members of the fragile X family under risk should be 
screened both by cytogenetic and molecular methods.
K e y  W o rd s : Fragile X syndrome, DNA analysis, 
Mosaicism, StB12,3 probe.
IN T R O D U C T IO N
Fragile X syndrome is one of the most frequent genetic 
causes of mental retardation (MR); with an incidence 
of 1/4.000 in males and 1/5.000 in females (1,2). The 
mutations associated with the syndrome have been 
characterized (3), and the fragile X mental retardation
1 (FMR 1) gene has been cloned (3,4). Fragile X 
mutations consist of an increase in the size of a target 
fragment containing a trinucleotide (CGG)n repeats 
located in the 5’-UTR region of the FMR-1 gene (5-7). 
The triplet repeats in FMR-1 gene normally vary in 
size. Between 6 to 54 repeats are considered normal, 
between 54 and 200, and more than 200 repeats are 
considered premutation and full mutation, respectively 
(8-10). A normal man carrying premutated allele is 
called “normal transmitting male" (NTM) and has a 
high risk of having affected grandsons (11). Some 
affected individuals could be mosaics with coexistence 
of premutations and full mutations (11-13). These 
expansions would be expressed as a fragile site at 
Xq27.3 locus (FRAXA) by cytogenetic analysis using 
international fragile X induction systems (14,15).
M A TE R IA LS  A N D  M E TH O D S
The subjects investigated in our laboratory were 
families of six probands with mental retardation, 
developmental delay and behavioral problems. 
Together with 6 affected individuals 36 relatives were 
investigated both by cytogenetic and molecular 
analysis. All families were from Antalya or its 
surrounding regions. Sixteen normal persons (8 
males, 8 females) were used as controls. For fragile X 
induction, TC 199 with 5% FCS and TC 199 with MTX 
(10-7 M final concentration) were used. We have 
scored at least 100  and 200  metaphases for males and 
females, respectively.
Genomic DNA from 10 ml peripheral blood with EDTA 
was extracted by the salting-out method (16). Five 
micrograms of genomic DNA were double digested by 
EcoRI/Eagl, then blotted and hybridized with probe 
StB12.3 according to Rousseau et al (5).
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RESULTS
The results of the DNA and cytogenetic analysis of 
our families are given in Table I. Among the 17 
females at risk, 5 premutation, 9 full mutation, 1 
mosaic mutation were identified; whereas in the 19 
males at risk, 11 full mutations, and 1 atypical 
hybridization pattern were identified by Southern blot. 
Seven males and 3 females were found normal after 
DNA analysis.
Fig. 1 a shows the hybridization pattern of the Family Y. 
Y5 (II-4) was a cytogenetically positive female with 2 
percent of fragile X expression like her sister Y2(ll-3) 
and her mother Y8(l-2). Y5(ll-4) had three fragments 
which were 6.2, 5.2, and 2,8 kb instead of the 
expected 5.2 and 2.8 kb fragments in normal females 
by EcoRI/Eagl double digestion. Y3 (111-1) and Y4 (III- 
2) had full mutation (approximately a 7.0 kb-fragment) 
(Fig. 1a).
T a b le  I. Summary of molecular and cytogenetic results of families with fragile X syndrome.
FAMILIES SEX  FRAGILE X (%) DNA MUTATION *
T C 199  + T C 1 9 9  (MTX 10 7) N P F
FAMILY A
A1 M - +
A2 F 8 +
A3 M 8 +
A4 M 13 +
A5 F - +
A6 F 13 +
A7 M 3 +
A8 M 8 +
FAMILY Y
Y1 M - +
Y2 F 2
Y3 M 7 +
Y4 M 32 +
Y5 F 2 +
Y6 M 16 +
Y7 F 3 +
Y8 F 2 +
FAMILY B
B1 M 20 +
B2 F 3 +
B3 M -
B4 M - +
B5 F - +
B6 F 2 +
FAMILY S
S1 M 13 +
S2 F +
S3 F 2 +
S4 M - +
FAMILY TR
TR1 M - +
TR2 F 5 +
TR3 M 18 +
TR4 F 16 +
TR5 F 2 +
FAMILY TL
TL1 M 24 +
TL2 F - +
TL3 M - +
TL4 F 5 +
TL5 M - +
* N= Normal, P= Premutation, F= Full mutation, M= Mosaic, A= Atypical pattern.
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Fig. 1 b shows the hybridization pattern of the Family B. 
B2 (II-4) and her mother B6(l-2) were cytogeneticially 
positive, and had premutations with increasedr repeat 
size (0.2 kb). B3(ll-3) was cytogenetically negative and 
clinically normal male who had atypical hybridization 
pattern probably due to incomplete digestion, instead 
of the expected 2 .8  kb fragment for normal males 
(Fig.1b). The instability and abnormal methylation of 
the CGG repeats were in agreement with clinical 
phenotype in all members of tested families. Also, 
there was anticipation of CGG repeats in families with 
three generations, as expected.
D IS C U S S IO N
The family members of fragile X syndrome patients 
with or without clinical features should be screened by 
molecular methods. Coexistence of the full and 
premutation carriers has been described in fragile X 
families. Mosaicism has been detected with a higher 
prevalence in males (5,9,10,13,17). In the present 
study one female (Y2, in Table 1.) who was 
cytogenetically positive was found to be mosaic by 
DNA analysis (Fig.1). The ratio and the distribution of
mosaicism in tissues is not known. Y5’s (II-4) mother 
Y8(l-2) has the premutation (5.2 and 3.0 kb), her sister 
Y2 (II-3) has the mosaic and her brother Y6 (II-2) has 
the full mutation patterns ranging from 6.0  to 6 .6  kb. 
B2(ll-4) has the premutation and her mentally retarded 
son (111-1) has a full mutation (Fig.1b). Our data 
suggests that the families of the fragile X syndrome 
should be definetly investigated by molecular tests. 
The proportion of methylation plays an important role 
in the expression of FMR 1 gene. Our data shows an 
agreement with previously reported studies (18-20). 
For appropriate genetic counseling cytogenetic 
analysis should be performed on clinically suspected 
fragile X cases to rule out other chromosome 
abnormalities. In addition, all relatives under risk 
should be screened by molecular tests.
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F ig . l . :  Pedigrees and StB12.3 hybridization patterns of EcoRI/Eagl double-digested DNA 
samples; a) from Family Y; Y2(ll-3): mosaic female with normal allele, b) from 
Family B; B2(ll-4): a female with premutation, B3(ll-3): a male with atypical 
hybridization pattern, and B4(ll-2): normal male.
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